SCHEMBL7424438

SCHEMBL7424438

OC(CCCN1CCN(CCOC(c2ccc(F)cc2)c2ccc(F)cc2)CC1)c1cccs1

nearest known ligand 0.89

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 0.67
SLC6A4 P31645 5/20 0.61
SLC6A3 Q01959 5/20 0.61
SLC6A2 P23975 3/20 0.57
MEN1 O00255 2/20 0.57
ALDH1A1 P00352 2/20 0.57
LMNA P02545 2/20 0.57
MAPK1 P28482 2/20 0.57
KMT2A Q03164 2/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
TDP1 Q9NUW8 2/20 0.57
NPC1 O15118 1/20 0.57
TP53 P04637 1/20 0.57
CYP1A2 P05177 1/20 0.57
CYP3A4 P08684 1/20 0.57
CYP2D6 P10635 1/20 0.57
MAPT P10636 1/20 0.57
CYP2C9 P11712 1/20 0.57
TSHR P16473 1/20 0.57
NFKB1 P19838 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10635083 0.83 SLC6A4 (0.77) SIGMAR1SLC6A4SLC6A3SLC6A2MEN1
SCHEMBL10635609 0.82 SLC6A4 (0.88) SIGMAR1SLC6A4SLC6A3SLC6A2MEN1
Hydrochloric Acid SCHEMBL11077810 0.81 SLC6A4 (0.86) SIGMAR1SLC6A4SLC6A3SLC6A2MEN1
SCHEMBL7419078 0.78 SIGMAR1 (0.65) SIGMAR1SLC6A4SLC6A3SLC6A2MEN1
SCHEMBL10631998 0.78 SLC6A4 (0.90) SLC6A4SLC6A3
SCHEMBL1578007 0.78 SLC6A4 (0.59) SIGMAR1SLC6A4SLC6A3SLC6A2MEN1
SCHEMBL10551886 0.78 SIGMAR1 (0.73) SIGMAR1SLC6A4SLC6A3SLC6A2MEN1
Hydrochloric Acid SCHEMBL10632291 0.77 SLC6A4 (0.88) SLC6A4SLC6A3
SCHEMBL7720831 0.76 SLC6A4 (1.00) SLC6A4SLC6A3SLC6A2
SCHEMBL10552245 0.76 SLC6A4 (0.78) SIGMAR1SLC6A4SLC6A3SLC6A2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0541617-B1 1,4-DISUBSTITUTED PIPERAZINES NOVO NORDISK AS (DK) 1997-06-04 EP disclosed
US-5276035-A Central nervous system disorders; Parkinson's disease; antidepressant and dopaminergic agent NOVO NORDISK A/S (DK) 1994-01-04 US disclosed
EP-0541617-A1 1,4-DISUBSTITUTED PIPERAZINES. NOVO NORDISK AS (DK) 1993-05-19 EP disclosed
WO-1992001679-A1 1,4-DISUBSTITUTED PIPERAZINES NOVO NORDISK A/S (DK) 1992-02-06 WO disclosed